IceCure Medical (ICCM) Cash from Operations (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Cash from Operations data on file, last reported at 4271000.0 in Q1 2026.

• Cash from Operations for Q1 2026 came in at 4271000.0, down 5.77% year-over-year; the trailing twelve-month figure through Mar 2026 was 14807000.0 (down 7.7% YoY), and the FY2025 annual result was 14574000.0, down 16.01% from the prior year.
• Cash from Operations advanced to 4271000.0 in Q1 2026 per ICCM's latest filing, from 5019000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 2304000.0 in Q4 2023 and troughed at 5019000.0 in Q4 2025.
• A 5-year average of 3426470.59 and a median of 3319000.0 in 2022 frame the typical range for Cash from Operations.
• The sharpest annual moves came in 2022 and 2023: Cash from Operations tumbled 120.31% in 2022, then surged 44.19% in 2023.
• A 5-year view of Cash from Operations shows it stood at 4128000.0 in 2022, then surged by 44.19% to 2304000.0 in 2023, then tumbled by 82.07% to 4195000.0 in 2024, then fell by 19.64% to 5019000.0 in 2025, then increased by 14.9% to 4271000.0 in 2026.
• Business Quant data shows ICCM's Cash from Operations at 4271000.0 in Q1 2026, 5019000.0 in Q4 2025, and 2705000.0 in Q3 2025.